Blog
Protecting Patients and the Responsibilities of the MA Holder
When new information regarding the risks and benefits of a product is established after a Pharmacovigilance investigation, it is prudent that changes are made to the safety information of that product. Patient Information Leaflets must be updated for Health Care Professionals and patients in order to use or prescribe the product safely.
EMVO announced their office is moving!
EMVO announced their office is moving to a new address!
Quality Technical Agreements “QTAs” or “TA”
When did you last review your QTAs?
Many hours are spent to gain agreement on the finer details
in your agreements as part of the on-boarding and approval process of a supplier or customer and once they are mutually agreed signed and dated by both parties they come into effect.
Qualification of Suppliers and Customers extra Due Diligence
In 2019 many companies were suspended for trading falsified medicines and were victims of fraud.
Cannabidiol and Clobazam
Cannabidiol and Clobazam can be prescribed to treat paediatric patients with seizures associated with Dravets or Lennox-Gastaut syndromes The latest guidance from National Institute for Health and Care Excellence “NICE”
Manufacturers, Wholesalers, Responsible Persons and Healthcare Professionals must consider how they communicate and what are the effective channels of communication they should consider to effectively get their message across.
The way the public is influenced is aided by technologies which facilitate messages to be spread at speed, and people trust the medias and or people who deliver the message often without question. They often sign up to follow their newfound friend who is now their trusted expert. People join groups and sign up to blogs and alerts and rarely question the bona fides.
A vaccine against Ebola will be available
European Medicines Agency EMA has given positive advice about granting a license for the first vaccine against the Ebola virus called Ervebo.
Cogent & GDP update Training
Here at Pharmacy Consulting, we offer Cogent & GDP update training every month at our Head Office and in Birmingham. Our courses cover the basics and the most recent updates given by the MHRA.
Counting down… Be prepared for the Brexit
As always get your checklist out and manage them to carry on trading, be able to receive from the EU/EEA and send out pharmaceutical goods from the UK. Make sure your organization is ready when Brexit hits. What should you have ready before Brexit happens? Check your:...
Shipping pharmaceuticals from Asia to Europe in comfort
MSC Gülsün announced that their first 23.000+teu vessel Container Ship has completed its landmark from Asia to Europe. This new container ship is built to have the largest capacity and be able to produce low CO2 emission to be environment friendly by lowering the carbon footprint during the supply chain.
Risk Management in Pharma
A probability or threat of damage, injury, liability, loss, or any other negative occurrence that is caused by external or internal vulnerabilities, and that may be avoided through preemptive action
GDP Responsible Person Cogent “Gold Standard” Training formally recognised by the MHRA
Over the last few years, many companies like ourselves have offered a number of courses to help companies train their employees about being compliant. For most companies, the current courses available are enough to ensure they understand what is excepted of them by the MHRA. Like most things, this is changing, and a basic understanding is not enough anymore. For those looking to be RPs (Responsible Persons) or even directors of companies they now need more in-depth training. Over the last year, we have been looking at a way into how Pharmacy Consulting can help business with this. Following this, we have been Cogent accredited and can offer our GDP Responsible Person Cogent “Gold Standard” Training formally recognised by the MHRA.